Tsedal Mebrahtu is the Director of the Clinical Operations Office (COO), which manages and oversees protocol development and provides regulatory support throughout the life cycle of each MHRP research protocol. Her team ensures completion of all required regulatory documents, manages Army level submission processes for review and approval or final determination and liaises with international staff to ensure they submit and receive all required in-country levels of approvals and clearances. Dually serving in both a regulatory and clinical operations role, the COO also plays an essential role in the management of clinical operations from initial trainings, protocol/site activation, to GCP monitoring, and ongoing protocol operational issues support until the completion of each study. Ms. Mebrahtu also serves as the CTU Coordinator for the MHRP Clinical Trials Unit.
Ms. Mebrahtu has over 18 years of combined clinical and programmatic research experience, both in the US and international settings. She previously served as the Clinical Operations Director for Africa for the International AIDS Vaccine Initiative (IAVI) and held various positions based overseas for UCSF and Johns Hopkins University Bloomberg School of Public health managing various phase I-III clinical trials and other research projects.